Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease

✍ Scribed by Maurits E. L. Arbouw; Kris L. L. Movig; Toine C. G. Egberts; Petra J. E. Poels; Jeroen P. P. van Vugt; Judith A. M. Wessels; R. J. H. M. van der Straaten; Cees Neef; Henk-Jan Guchelaar

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 117 KB
• Volume: 65
• Category: Article
• ISSN: 0031-6970
• DOI: 10.1007/s00228-009-0708-6